|
Delayed
TEL AVIV STOCK EXCHANGE
18:24:57 17/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,066.00 ILa | 0.00% |
|
+0.19% | -2.56% |
| Market Cap | 122M 0 41.05M 35.43M 33.24M 30.28M 56.93M 3.92B 57.72M 390M 153M 1.97B 154M 151M 6.54B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 250M 0 84.23M 72.71M 68.22M 62.13M 117M 8.05B 118M 800M 313M 4.03B 316M 309M 13.42B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +0.19% | ||
| Current month | -1.84% | ||
| 1 month | -2.11% | ||
| 3 months | -3.27% | ||
| 6 months | -13.40% | ||
| Current year | -2.56% |
| 1 week | 1,050 |  | 1,066 |
| 1 month | 1,040 | | 1,144 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,788 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 24/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 01/11/2018 |
| President | 80 | 28/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 25/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 15/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +0.19% | -9.35% | -34.08% | 41.05M | |
| -1.04% | -2.27% | +27.76% | +106.24% | 100B | |
| +0.21% | -0.64% | +57.52% | +172.79% | 54.81B | |
| -1.69% | -2.36% | +1.40% | +279.08% | 24.13B | |
| -0.72% | -1.50% | -12.44% | -15.93% | 8.19B | |
| -0.94% | -0.64% | -31.55% | -23.57% | 7.66B | |
| +0.65% | +0.48% | -12.65% | -20.24% | 6.68B | |
| -0.53% | +3.47% | +11.25% | +22.49% | 6.42B | |
| -0.06% | -0.86% | -3.58% | +16.82% | 4.98B | |
| -1.38% | -1.19% | -6.55% | -9.06% | 3.69B | |
| Average | -0.60% | -0.65% | +2.18% | +49.46% | 21.69B | |
| Weighted average by Cap. | -0.82% | -1.34% | +25.69% | +122.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 109M 93.69M 87.89M 80.05M 151M 10.38B 153M 1.03B 404M 5.2B 407M 399M 17.29B | 301M 0 102M 87.65M 82.23M 74.9M 141M 9.71B 143M 964M 378M 4.86B 381M 373M 16.18B |
| Net income | 6.21M 0 2.09M 1.81M 1.7M 1.54M 2.9M 200M 2.94M 19.88M 7.79M 100M 7.86M 7.69M 334M | -18.07M -0 -6.1M -5.26M -4.94M -4.5M -8.46M -583M -8.57M -57.89M -22.68M -292M -22.89M -22.39M -971M |
| Net Debt | 127M 0 42.87M 37.01M 34.72M 31.62M 59.46M 4.1B 60.29M 407M 159M 2.05B 161M 157M 6.83B | 128M 0 43.18M 37.28M 34.97M 31.85M 59.9M 4.13B 60.73M 410M 161M 2.07B 162M 159M 6.88B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | ILA 1,066.00 | 0.00% | 404 |
| 14/08/26 | ILA 1,066.00 | 0.00% | 1 |
| 13/08/26 | ILA 1,066.00 | 0.00% | 2 |
| 12/08/26 | ILA 1,066.00 | -0.19% | 302 |
| 11/08/26 | ILA 1,068.00 | +0.38% | 202 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
